Literature DB >> 20020140

Willingness to pay for improvement of physical function among rheumatoid arthritis patients as measured by Health Assessment Questionnaire.

Risto Tuominen1, Michael Azbel, Joonas Hemmilä, Timo Möttönen.   

Abstract

The main objective of this study was to assess the symptoms and functional difficulties caused by rheumatoid arthritis through application of the willingness to pay (WTP) method. Structured questionnaire study was conducted among 242 RA patients. The subjects were asked to evaluate their functional capacity using visual analog scales (VAS) for all the 20 questions in the Health Assessment Questionnaire (HAQ). Each VAS was followed by a question asking how much the respondent would be willing to pay on a monthly basis for a 50% improvement with the function in question. These were combined with later collected data on clinical status and use of RA-related health services. The average WTP varied greatly in the examined 20 different functions. The total WTP average on a 50% improved functional capacity amounted to <euro> 567.05 per month. Patients with lower functional capacity (HAQ 1.2 or more) were ready to contribute significantly (p < 0.001) more (705 euros/month) than those with better functional status (199 euros/month). Subjects, whose financial standing was better, reported a higher total WTP (r = 0.218, p < 0.01). On average, the total WTP of the respondents equaled 18.44% of the disposable net monthly income per person of the household. However, the variation was quite substantial. WTP among patients with rheumatoid arthritis was best depicted through the functional capacity of the patient, the possible time the patient had retired, and the global feeling of pain. In conclusion, monetary value is a concrete way of portraying subjective valuation. WTP method is suitable for assessing functional deficits of rheumatoid arthritis.

Entities:  

Mesh:

Year:  2009        PMID: 20020140     DOI: 10.1007/s00296-009-1280-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  14 in total

1.  The economic evaluation of health care.

Authors:  M Haas; J Hall
Journal:  Health Inf Manag       Date:  1998 Dec-1999 Feb       Impact factor: 3.185

2.  Epidemiology of rheumatoid arthritis in Finland.

Authors:  K Aho; O Kaipiainen-Seppänen; M Heliövaara; T Klaukka
Journal:  Semin Arthritis Rheum       Date:  1998-04       Impact factor: 5.532

3.  Rheumatology outcomes: the patient's perspective.

Authors:  Alison Carr; Sarah Hewlett; Rod Hughes; Helene Mitchell; Sarah Ryan; Maggie Carr; John Kirwan
Journal:  J Rheumatol       Date:  2003-04       Impact factor: 4.666

4.  Willingness to pay in arthritis: a Danish contribution.

Authors:  U Slothuus; R G Brooks
Journal:  Rheumatology (Oxford)       Date:  2000-07       Impact factor: 7.580

5.  The Health Assessment Questionnaire (HAQ).

Authors:  B Bruce; J F Fries
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

6.  Values for function in rheumatoid arthritis: patients, professionals, and public.

Authors:  S Hewlett; A P Smith; J R Kirwan
Journal:  Ann Rheum Dis       Date:  2001-10       Impact factor: 19.103

7.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

8.  Costs of rheumatoid arthritis: new estimates from the human capital method and comparison to the willingness-to-pay method.

Authors:  Bruno Fautrel; Ann E Clarke; Francis Guillemin; Viviane Adam; Yvan St-Pierre; Tina Panaritis; Paul R Fortin; Henri A Menard; Cam Donaldson; John R Penrod
Journal:  Med Decis Making       Date:  2007 Mar-Apr       Impact factor: 2.583

9.  Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective.

Authors:  Bruno Fautrel; Ann E Clarke; Francis Guillemin; Viviane Adam; Yvan St-Pierre; Tina Panaritis; Paul R Fortin; Henri A Menard; Cam Donaldson; John R Penrod
Journal:  J Rheumatol       Date:  2005-03       Impact factor: 4.666

10.  The burden of rheumatoid arthritis and access to treatment: health burden and costs.

Authors:  J Lundkvist; F Kastäng; G Kobelt
Journal:  Eur J Health Econ       Date:  2008-01
View more
  2 in total

1.  Valuing Treatment With Infliximab for Ankylosing Spondylitis Using a Willingness-to-Pay Approach.

Authors:  Casper Webers; Ivette Essers; Astrid van Tubergen; Jürgen Braun; Frank Heldmann; Xenofon Baraliakos; Annelies Boonen
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-02-18       Impact factor: 4.794

2.  From drug-delivery device to disease management tool: a study of preferences for enhanced features in next-generation self-injection devices.

Authors:  Marco Boeri; Boglarka Szegvari; Brett Hauber; Brennan Mange; Irina Mountian; Michael Schiff; Nikolaos Maniadakis
Journal:  Patient Prefer Adherence       Date:  2019-07-11       Impact factor: 2.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.